Skip to main content
978-487-1100

One YMC

YMC America recently hosted colleagues from Japan for a two-week training on YMC’s patented process scale Contichrom TWIN MCSGP technology to support the growing demand in Asia.  We may live on different continents, but we are one YMC family!

Captured in the picture from left to right:
Front row: Naoko Ushimaru-Aslop, Translator; Hoshino Tetsuro, Software Development; Ebi Takahiro, Continuous Chromatography & Lab Services
2nd row: Mario Lopez, Engineering Manager; Haibo Mao, Automation & R&D Manager; Mark Dyment, President & CEO; Shoda Munehiro, Process Development; Yano Tomohiro, System Development
Back row: Kofi Hanson, Sr. Automation Engineer; Dave Brush, Sr. Process Engineer; Emmett Bishop, Automation Engineer
Missing: Igawa Hideto, Key Account Sales; Takimoto Kiyotaka, Business Development; J Preston, Director of Separation Sciences

YMC strives to provide high quality products and support to all of our customers around the world.  The training completed by our colleagues will ensure that every system like the one shown below can be supported with YMC care and expertise.  This custom-designed Contichrom TWIN 500 MCSGP HPLC recently left our production facility in Devens, MA, USA, headed for its new home!


Posted on February 16, 2023.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.
Read More

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.
Read More

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.
Read More

Designed and developed by